First description of bacteremia caused by Oscillibacter valericigenes in a patient hospitalized for leg amputation.
Amputation, Surgical
Anti-Bacterial Agents
/ therapeutic use
Bacteremia
/ diagnosis
Bacterial Typing Techniques
Clostridiales
/ classification
DNA, Bacterial
/ genetics
Hospitalization
Humans
Leg
/ surgery
Male
Middle Aged
Phylogeny
Piperacillin, Tazobactam Drug Combination
/ therapeutic use
RNA, Ribosomal, 16S
/ genetics
16S sequencing
Joint and bone infection
Molecular diagnosis
Oscillibacter
Journal
Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
13
01
2020
revised:
07
07
2020
accepted:
15
07
2020
pubmed:
28
7
2020
medline:
9
6
2021
entrez:
27
7
2020
Statut:
ppublish
Résumé
Initially isolated from the alimentary canal of a Japanese corbicula clam, Oscillibacter valericigenes is a Gram-negative rod, of which culture remains very difficult. Herein we present the first case of bacteremia due to Oscillibacter valericigenes, in humans. A 55-year-old man was hospitalized for clinical management of multiple neglected leg wounds (colonized with maggots) that had occurred during a motorcycle accident. Following radiological confirmation of the bone infection, a transfemoral amputation was performed to limit the risk of extended infection. During hospitalization, before the amputation, the patient experienced fever, biological inflammation justifying the sampling of multiple blood cultures. Anaerobic blood culture was positive after 34 hours, without identification by routine procedure (MALDI-TOF), justifying identification by 16S DNA sequencing. In the absence of possible subculture, antibiotic sensitivity testing could not be performed. A pre-emptive treatment by piperacillin-tazobactam was introduced for 14 days. The evolution was good, except for a local disunion. Complete phylogenic analysis of the clinical strain showed that it significantly differed from the reference strain, which is distantly related to the Clostridia cluster IV. Due to the culture conditions and specialized identification method by sequencing, prevalence of O. valericigenes may be underestimated. Optimization of blood culture procedures and utilization of 16S rRNA gene sequencing are tools needed for identification of rare pathogens that could help to optimize clinical management of infected patients.
Identifiants
pubmed: 32712374
pii: S1075-9964(20)30100-1
doi: 10.1016/j.anaerobe.2020.102244
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
DNA, Bacterial
0
RNA, Ribosomal, 16S
0
Piperacillin, Tazobactam Drug Combination
157044-21-8
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102244Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.